Target intelligence / Profile preview

Gut microbial ecological niches (Lactobacillus rhamnosus)

Molecular classification
Other
01

Overview

The gut microbial ecological niche of Lactobacillus rhamnosus, specifically the GG strain (LGG), represents the complex interplay of physical space and nutrient availability required for bacterial persistence in the human gastrointestinal tract. LGG is a highly studied probiotic that colonizes the gut by adhering to intestinal mucus via specialized SpaCBA pili and competing for 'metabolic space' through the utilization of specific carbohydrates (Kankainen et al., 2009, PNAS). This niche is not a single molecular target but a biological environment where L. rhamnosus exerts therapeutic effects by preventing the settlement of pathogens and producing metabolites that strengthen the intestinal barrier (Lebeer et al., 2010, Nature Reviews Microbiology). Clinical interventions often focus on supplementing this niche with exogenous LGG to treat dysbiosis-related conditions such as antibiotic-associated diarrhea and inflammatory bowel disease (Segers & Lebeer, 2014, Microbial Cell Factories). Understanding the shared metabolic requirements between different L. rhamnosus strains is critical for predicting how these populations interact and stabilize within the broader human microbiome.

Other names
Lactobacillus rhamnosus GG ecological nicheLGG metabolic spaceLacticaseibacillus rhamnosus colonization siteMicrobial niche competition
02

Mechanism of action

Competitive exclusion of pathogens by occupying physical attachment sites and depleting shared metabolic resources (metabolic space), alongside the production of antimicrobial bacteriocins and modulation of host epithelial signaling.

03

Biological functions

Bacterial colonizationMetabolic competitionNiche exclusionImmune modulationShort-chain fatty acid productionMucosal adhesion
04

Disease associations

DysbiosisGastrointestinal infectionInflammatory bowel diseaseAntibiotic-associated diarrheaAtopic dermatitis
05

Safety considerations

Risk of sepsis or bacteremia in severely immunocompromised patientsPotential for horizontal gene transfer of antibiotic resistanceStrain-specific variations in metabolic activity and colonization efficiency
06

Interacting drugs

Lactobacillus rhamnosus GG (Probiotic)

2 more in the full profile.

07

Biomarkers

Lactobacillus rhamnosus abundance (fecal DNA)Fecal short-chain fatty acid (SCFA) levelsIntestinal permeability markersSecretory IgA levels

Beyond the preview

Go deeper on Gut microbial ecological niches (Lactobacillus rhamnosus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbial ecological niches (Lactobacillus rhamnosus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call